The latest pharma updates spotlight key developments in drug safety, regulatory compliance, clinical practice, disease preparedness and global ambitions
Chandipura Virus cases have surged in Gujarat, with the death toll reaching 27. The state has reported 41 confirmed infections so far. The outbreak has raised concern due to the virus's rapid progression. Chandipura virus cases have mainly been...
India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
Manufacturing quality at Aurobindo Pharma's Eugia business faces renewed scrutiny after the US Food and Drug Administration issued a warning letter to its Unit-I facility in Telangana
Drug quality has become a bigger regulatory priority in India as authorities intensify inspections to strengthen manufacturing standards
Osteoarthritis treatment could see a new stem cell-based approach after Bengaluru-based Stempeutics Research secured a US patent.
Drug Resistance is becoming harder to manage as bacteria stop responding to commonly used antibiotics. Wockhardt is now targeting this challenge through a new scientific learning platform.
Drug approvals, MedTech innovation, and pharma legal battles are driving major healthcare developments across global and Indian markets
Indian pharma is gaining a stronger foothold in Nigeria as bilateral economic ties expand and companies deepen their presence across Africa
Gujarat is drawing fresh pharma investment worth INR 2,500-3,000 crore. The money is going into new drug manufacturing facilities across the state. The investment follows approvals for 59 new allopathic medicine plants during FY2025-26.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")